Cargando…

A method to prevail false positive responses due to excess cations and viscous nature of Radiopharmaceuticals in Limulus Amebocyte Lysate Gel Clot test

OBJECTIVE(S): Bacterial endotoxin test (BET) for detection and quantification of endotoxin in radiopharmaceuticals (RPs), used for therapy or diagnosis, is prerequisite to administration in patients. Out of the two established methods used for this purpose (Kinetic Chromogenic Assay: KCM and Gel Clo...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitra, Arpit, Lad, Sangita, Sahu, Sudeep, Kulkarni, Savita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mashhad University of Medical Sciences 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205850/
https://www.ncbi.nlm.nih.gov/pubmed/35800418
http://dx.doi.org/10.22038/AOJNMB.2021.59607.1416
_version_ 1784729216652148736
author Mitra, Arpit
Lad, Sangita
Sahu, Sudeep
Kulkarni, Savita
author_facet Mitra, Arpit
Lad, Sangita
Sahu, Sudeep
Kulkarni, Savita
author_sort Mitra, Arpit
collection PubMed
description OBJECTIVE(S): Bacterial endotoxin test (BET) for detection and quantification of endotoxin in radiopharmaceuticals (RPs), used for therapy or diagnosis, is prerequisite to administration in patients. Out of the two established methods used for this purpose (Kinetic Chromogenic Assay: KCM and Gel Clot Bacterial Endotoxin Test: GC-BET), GC-BET is recommended by pharmacopeias to evaluate the interferences exhibited during the assay due to presence of various ingredients in samples. In the present study, the influence of excess of cations in [(177)Lu]Lu-DOTATATE, used for Peptide Receptor Radionuclide Therapy (PRRT), were studied and a protocol to negate the enhancement observed was developed. Additionally, a protocol for carrying out GC-BET for extremely viscous [(131)I]I-Lipiodol was standardized. METHODS: GC-BET was performed for [(177)Lu]Lu-DOTATATE and [(131)I]I-Lipiodol at maximum valid dilution (MVD), using LRW as a diluent. To negate the false positivity observed in case of [(177)Lu]Lu-DOTATATE, various concentrations of calcium chloride (CaCl(2)) were added and evaluated for the reversal of the interference observed initially. To prevail the difficulty in performing GC-BET for [(131)I]I-Lipiodol various modification in the protocols like orbital vortexing at different rpm and time intervals were performed. KCM assays were also performed for studied RPs at MVD. RESULTS: It was observed that at MVD, [(177)Lu]Lu-DOTATATE exhibited false positivity in GC-BET. However, all the individual reagents used in labeling of [(177)Lu]Lu-DOTATATE did not show any false positivity. Finally, performing the assay with an addition of 2mM CaCl(2) (final concentration) nullified the false positivity. Further, intricacy in performing GC-BET for [(131)I]I-Lipiodol due to its viscosity was resolved by orbital vortexing at 3000 rpm for 5 minutes. CONCLUSIONS: Our study proved that false positivity was observed in GC-BET for [(177)Lu]Lu-DOTATATE due to the presence excess M(3+) ions. Further, our study is the first of its kind which demonstrated methods for negating these false positive results by using modified protocol and hypothesizing the reason behind the enhancement. Additionally, ours is the first study which proved that a simple step of vortexing the viscous RPs like [(131)I]I-Lipiodol can resolved the problems encountered during performing GC-BET due to viscosity of RPs.
format Online
Article
Text
id pubmed-9205850
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Mashhad University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-92058502022-07-06 A method to prevail false positive responses due to excess cations and viscous nature of Radiopharmaceuticals in Limulus Amebocyte Lysate Gel Clot test Mitra, Arpit Lad, Sangita Sahu, Sudeep Kulkarni, Savita Asia Ocean J Nucl Med Biol Original Article OBJECTIVE(S): Bacterial endotoxin test (BET) for detection and quantification of endotoxin in radiopharmaceuticals (RPs), used for therapy or diagnosis, is prerequisite to administration in patients. Out of the two established methods used for this purpose (Kinetic Chromogenic Assay: KCM and Gel Clot Bacterial Endotoxin Test: GC-BET), GC-BET is recommended by pharmacopeias to evaluate the interferences exhibited during the assay due to presence of various ingredients in samples. In the present study, the influence of excess of cations in [(177)Lu]Lu-DOTATATE, used for Peptide Receptor Radionuclide Therapy (PRRT), were studied and a protocol to negate the enhancement observed was developed. Additionally, a protocol for carrying out GC-BET for extremely viscous [(131)I]I-Lipiodol was standardized. METHODS: GC-BET was performed for [(177)Lu]Lu-DOTATATE and [(131)I]I-Lipiodol at maximum valid dilution (MVD), using LRW as a diluent. To negate the false positivity observed in case of [(177)Lu]Lu-DOTATATE, various concentrations of calcium chloride (CaCl(2)) were added and evaluated for the reversal of the interference observed initially. To prevail the difficulty in performing GC-BET for [(131)I]I-Lipiodol various modification in the protocols like orbital vortexing at different rpm and time intervals were performed. KCM assays were also performed for studied RPs at MVD. RESULTS: It was observed that at MVD, [(177)Lu]Lu-DOTATATE exhibited false positivity in GC-BET. However, all the individual reagents used in labeling of [(177)Lu]Lu-DOTATATE did not show any false positivity. Finally, performing the assay with an addition of 2mM CaCl(2) (final concentration) nullified the false positivity. Further, intricacy in performing GC-BET for [(131)I]I-Lipiodol due to its viscosity was resolved by orbital vortexing at 3000 rpm for 5 minutes. CONCLUSIONS: Our study proved that false positivity was observed in GC-BET for [(177)Lu]Lu-DOTATATE due to the presence excess M(3+) ions. Further, our study is the first of its kind which demonstrated methods for negating these false positive results by using modified protocol and hypothesizing the reason behind the enhancement. Additionally, ours is the first study which proved that a simple step of vortexing the viscous RPs like [(131)I]I-Lipiodol can resolved the problems encountered during performing GC-BET due to viscosity of RPs. Mashhad University of Medical Sciences 2022 /pmc/articles/PMC9205850/ /pubmed/35800418 http://dx.doi.org/10.22038/AOJNMB.2021.59607.1416 Text en © 2022 mums.ac.ir All rights reserved https://creativecommons.org/licenses/by/3.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/ (https://creativecommons.org/licenses/by/3.0/) ) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Mitra, Arpit
Lad, Sangita
Sahu, Sudeep
Kulkarni, Savita
A method to prevail false positive responses due to excess cations and viscous nature of Radiopharmaceuticals in Limulus Amebocyte Lysate Gel Clot test
title A method to prevail false positive responses due to excess cations and viscous nature of Radiopharmaceuticals in Limulus Amebocyte Lysate Gel Clot test
title_full A method to prevail false positive responses due to excess cations and viscous nature of Radiopharmaceuticals in Limulus Amebocyte Lysate Gel Clot test
title_fullStr A method to prevail false positive responses due to excess cations and viscous nature of Radiopharmaceuticals in Limulus Amebocyte Lysate Gel Clot test
title_full_unstemmed A method to prevail false positive responses due to excess cations and viscous nature of Radiopharmaceuticals in Limulus Amebocyte Lysate Gel Clot test
title_short A method to prevail false positive responses due to excess cations and viscous nature of Radiopharmaceuticals in Limulus Amebocyte Lysate Gel Clot test
title_sort method to prevail false positive responses due to excess cations and viscous nature of radiopharmaceuticals in limulus amebocyte lysate gel clot test
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205850/
https://www.ncbi.nlm.nih.gov/pubmed/35800418
http://dx.doi.org/10.22038/AOJNMB.2021.59607.1416
work_keys_str_mv AT mitraarpit amethodtoprevailfalsepositiveresponsesduetoexcesscationsandviscousnatureofradiopharmaceuticalsinlimulusamebocytelysategelclottest
AT ladsangita amethodtoprevailfalsepositiveresponsesduetoexcesscationsandviscousnatureofradiopharmaceuticalsinlimulusamebocytelysategelclottest
AT sahusudeep amethodtoprevailfalsepositiveresponsesduetoexcesscationsandviscousnatureofradiopharmaceuticalsinlimulusamebocytelysategelclottest
AT kulkarnisavita amethodtoprevailfalsepositiveresponsesduetoexcesscationsandviscousnatureofradiopharmaceuticalsinlimulusamebocytelysategelclottest
AT mitraarpit methodtoprevailfalsepositiveresponsesduetoexcesscationsandviscousnatureofradiopharmaceuticalsinlimulusamebocytelysategelclottest
AT ladsangita methodtoprevailfalsepositiveresponsesduetoexcesscationsandviscousnatureofradiopharmaceuticalsinlimulusamebocytelysategelclottest
AT sahusudeep methodtoprevailfalsepositiveresponsesduetoexcesscationsandviscousnatureofradiopharmaceuticalsinlimulusamebocytelysategelclottest
AT kulkarnisavita methodtoprevailfalsepositiveresponsesduetoexcesscationsandviscousnatureofradiopharmaceuticalsinlimulusamebocytelysategelclottest